| Pay vs Performance Disclosure - USD ($) | 2 Months Ended | 10 Months Ended | 12 Months Ended |
| Dec. 31, 2020 | Oct. 31, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
| Pay vs Performance Disclosure [Table] | | | | | |
| Pay vs Performance [Table Text Block] | | | Value of Initial Fixed $100 Investment Based On: Fiscal Summary Compensation Table (“ SCT ”) for Dr. Seeto (PEO 1) (b) (1) CAP to Dr. Seeto (PEO 1) (c) (2) SCT for Dr. Maag (PEO 2) (d) (1) CAP to Dr. Maag (PEO 2) (e) (2) Average SCT for Non-PEO NEOs (f) (3) Average CAP to Non-PEO NEOs (g) (2) TSR (h) (4) Peer Group TSR (i) (4) Net Revenue (in thousands) (k) (5) 2022 $12,786,270 ($648,097) - - $3,784,612 $118,224 $52.90 $113.65 ($76,613) $321,793 2021 $7,090,121 ($50,411) - - $2,605,699 $140,603 $210.85 $126.45 ($30,662) $296,397 2020 $5,618,698 $17,196,016 $6,400,015 $32,731,502 $1,979,508 $7,956,557 $335.88 $126.42 ($18,714) $192,194 | | |
| Company Selected Measure Name | | | Revenue | | |
| Named Executive Officers, Footnote [Text Block] | | | The dollar amounts reported in columns (b) and (d) are the amounts of total compensation reported for Dr. Seeto (Chief Executive Officer and Principal Executive Officer since November 1, 2020) and Dr. Maag (Chief Executive Officer until November 1, 2020) for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Summary Compensation Table” on page 66 for additional information. The dollar amounts reported in column (f) are the average amounts of total compensation reported for the Non-PEO NEOs for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to our “Summary Compensation Table” on page 66 for additional information. For each of fiscal year 2020, 2021 and 2022, the Non-PEO NEOs were: 2022 2021 2020 Abhishek Jain Ankur Dhingra Michael Bell Alex Johnson Alex Johnson Sasha King Abraham Ronai Sasha King Marcel Konrad Ankur Dhingra Peter Maag, Ph. D. Sasha King Marcel Konrad | | |
| Peer Group Issuers, Footnote [Text Block] | | | TSR is determined based on the value of an initial fixed investment of $100. The TSR peer group consists of the Nasdaq Biotech Index companies . TSR is calculated by dividing (i) the difference between the stock price at the end of each measurement period shown and the beginning of the measurement period by (ii) the stock price at the beginning of the measurement period. | | |
| PEO Total Compensation Amount | | | $ 12,786,270 | $ 7,090,121 | |
| PEO Actually Paid Compensation Amount | | | $ (648,097) | (50,411) | |
| Adjustment To PEO Compensation, Footnote [Text Block] | | | The dollar amounts reported in columns (c), (e), and (g) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below. We do not have a defined benefit plan so no adjustment for pension benefits is included in the table below. Similarly, no adjustment is made for dividends as dividends are factored into the fair value of the award. Fiscal Year Executives SCT Grant Date Value of New Awards Year End Value of New Awards Change in Value of Prior Awards Change in Value of Vested Awards Change in Value of Equity Total Equity CAP CAP 2022 PEO 1 $12,786,270 $11,831,561 $3,650,780 ($3,545,193) ($1,708,393) - ($1,602,806) ($648,097) Others $3,784,612 $3,390,772 $860,477 ($553,061) ($273,019) ($310,012) ($275,616) $118,224 2021 PEO 1 $7,090,121 $5,576,681 $2,676,666 ($4,012,781) ($227,736) - ($1,563,851) ($50,411) Others $2,605,699 $1,973,681 $1,059,717 ($1,913,211) $362,080 - ($491,415) $140,603 2020 PEO 1 $5,618,698 $4,629,662 $11,125,170 $4,237,021 $844,788 - $16,206,980 $17,196,016 PEO 2 $6,400,015 $5,049,535 $14,469,675 $14,993,160 $1,918,187 - $31,381,022 $32,731,502 Others $1,979,508 $1,476,174 $3,841,379 $3,112,105 $499,739 - $7,453,222 $7,956,557 | | |
| Non-PEO NEO Average Total Compensation Amount | | | $ 3,784,612 | 2,605,699 | $ 1,979,508 |
| Non-PEO NEO Average Compensation Actually Paid Amount | | | $ 118,224 | 140,603 | 7,956,557 |
| Adjustment to Non-PEO NEO Compensation Footnote [Text Block] | | | The dollar amounts reported in columns (c), (e), and (g) represent the amount of the CAP, as computed in accordance with SEC rules. The CAP does not necessarily represent cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC rules. These amounts reflect the total amount of compensation for our NEOs reported in the Summary Compensation Table with certain adjustments as described in the table below. We do not have a defined benefit plan so no adjustment for pension benefits is included in the table below. Similarly, no adjustment is made for dividends as dividends are factored into the fair value of the award. Fiscal Year Executives SCT Grant Date Value of New Awards Year End Value of New Awards Change in Value of Prior Awards Change in Value of Vested Awards Change in Value of Equity Total Equity CAP CAP 2022 PEO 1 $12,786,270 $11,831,561 $3,650,780 ($3,545,193) ($1,708,393) - ($1,602,806) ($648,097) Others $3,784,612 $3,390,772 $860,477 ($553,061) ($273,019) ($310,012) ($275,616) $118,224 2021 PEO 1 $7,090,121 $5,576,681 $2,676,666 ($4,012,781) ($227,736) - ($1,563,851) ($50,411) Others $2,605,699 $1,973,681 $1,059,717 ($1,913,211) $362,080 - ($491,415) $140,603 2020 PEO 1 $5,618,698 $4,629,662 $11,125,170 $4,237,021 $844,788 - $16,206,980 $17,196,016 PEO 2 $6,400,015 $5,049,535 $14,469,675 $14,993,160 $1,918,187 - $31,381,022 $32,731,502 Others $1,979,508 $1,476,174 $3,841,379 $3,112,105 $499,739 - $7,453,222 $7,956,557 | | |
| Equity Valuation Assumption Difference, Footnote [Text Block] | | | The recalculated value of equity awards for each applicable year includes the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the applicable year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that vest in the applicable year, the change in the fair value as of the vesting date from the beginning of the applicable year; and | | |
| Compensation Actually Paid vs. Total Shareholder Return [Text Block] | | | | | |
| Compensation Actually Paid vs. Net Income [Text Block] | | | | | |
| Compensation Actually Paid vs. Company Selected Measure [Text Block] | | | | | |
| Total Shareholder Return Vs Peer Group [Text Block] | | | | | |
| Tabular List [Table Text Block] | | | 2022 Most Important Performance Measures The Compensation and Human Capital Committee uses a mix of performance measures throughout our annual and long-term incentive programs to align executive pay with Company performance. As required by SEC rules, the performance measures identified as the most important for all of our NEOs’ 2022 compensation decisions are listed in the table to the right. The measures in this table are not ranked. Most Important Performance Measures Revenue Adjusted EBITDA Pipeline Additions | | |
| Total Shareholder Return Amount | | | $ 52.90 | 210.85 | 335.88 |
| Peer Group Total Shareholder Return Amount | | | 113.65 | 126.45 | 126.42 |
| Net Income (Loss) | | | $ (76,613,000) | $ (30,662,000) | $ (18,714,000) |
| Company Selected Measure Amount | | | 321,793,000 | 296,397,000 | 192,194,000 |
| PEO Name | Dr. Seeto | Dr. Maag | Dr. Seeto | Dr. Seeto | |
| Additional 402(v) Disclosure [Text Block] | | | The dollar amounts reported in the Summary Compensation Table for the applicable year. (b) The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns of the Summary Compensation Table for the applicable year. We determined Revenue to be the most important financial performance measure used to link Company performance to the CAP to our PEOs and Non-PEO NEOs in 2022, consistent with the Total Sales targets used for our short-term incentives (annual bonuses) and long-term incentives (PRSUs). See page 48 of our CD&A for additional information. | | |
| Measure [Axis]: 1 | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Measure Name | | | Revenue | | |
| Measure [Axis]: 2 | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Measure Name | | | Adjusted EBITDA | | |
| Measure [Axis]: 3 | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Measure Name | | | Pipeline Additions | | |
| Dr. Seeto [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| PEO Total Compensation Amount | | | $ 12,786,270 | $ 7,090,121 | $ 5,618,698 |
| PEO Actually Paid Compensation Amount | | | (648,097) | (50,411) | 17,196,016 |
| Dr. Maag [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| PEO Total Compensation Amount | | | | | 6,400,015 |
| PEO Actually Paid Compensation Amount | | | | | 32,731,502 |
| PEO [Member] | Grant Date Value of New Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | 11,831,561 | 5,576,681 | |
| PEO [Member] | Year End Value of New Awrds [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | 3,650,780 | 2,676,666 | |
| PEO [Member] | Change in Value of Prior Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | (3,545,193) | (4,012,781) | |
| PEO [Member] | Change in Value of Vested Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | (1,708,393) | (227,736) | |
| PEO [Member] | Change in Value of Equity Awards That Failed to Meet Vesting Conditions [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | 0 | 0 | |
| PEO [Member] | Total Equity Compensation Actually Paid Adjustment [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | (1,602,806) | (1,563,851) | |
| PEO [Member] | Dr. Seeto [Member] | Grant Date Value of New Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | | | 4,629,662 |
| PEO [Member] | Dr. Seeto [Member] | Year End Value of New Awrds [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 11,125,170 |
| PEO [Member] | Dr. Seeto [Member] | Change in Value of Prior Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 4,237,021 |
| PEO [Member] | Dr. Seeto [Member] | Change in Value of Vested Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 844,788 |
| PEO [Member] | Dr. Seeto [Member] | Change in Value of Equity Awards That Failed to Meet Vesting Conditions [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 0 |
| PEO [Member] | Dr. Seeto [Member] | Total Equity Compensation Actually Paid Adjustment [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | | | 16,206,980 |
| PEO [Member] | Dr. Maag [Member] | Grant Date Value of New Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | | | 5,049,535 |
| PEO [Member] | Dr. Maag [Member] | Year End Value of New Awrds [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 14,469,675 |
| PEO [Member] | Dr. Maag [Member] | Change in Value of Prior Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 14,993,160 |
| PEO [Member] | Dr. Maag [Member] | Change in Value of Vested Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 1,918,187 |
| PEO [Member] | Dr. Maag [Member] | Change in Value of Equity Awards That Failed to Meet Vesting Conditions [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | | | 0 |
| PEO [Member] | Dr. Maag [Member] | Total Equity Compensation Actually Paid Adjustment [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | | | 31,381,022 |
| Non-PEO NEO [Member] | Grant Date Value of New Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | 3,390,772 | 1,973,681 | 1,476,174 |
| Non-PEO NEO [Member] | Year End Value of New Awrds [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | 860,477 | 1,059,717 | 3,841,379 |
| Non-PEO NEO [Member] | Change in Value of Prior Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | (553,061) | (1,913,211) | 3,112,105 |
| Non-PEO NEO [Member] | Change in Value of Vested Awards [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | (273,019) | 362,080 | 499,739 |
| Non-PEO NEO [Member] | Change in Value of Equity Awards That Failed to Meet Vesting Conditions [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount, Equity Awards | | | (310,012) | 0 | 0 |
| Non-PEO NEO [Member] | Total Equity Compensation Actually Paid Adjustment [Member] | | | | | |
| Pay vs Performance Disclosure [Table] | | | | | |
| Adjustment to Compensation Amount | | | $ (275,616) | $ (491,415) | $ 7,453,222 |
